Equity Details
Price & Market Data
Price: $62.11
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $44,193,333,248
Daily Volume: 0
Performance Metrics
1 Week: 0.16%
1 Month: -5.19%
3 Months: -5.98%
6 Months: -10.63%
1 Year: -7.97%
YTD: -7.30%
About Lonza Group AG (LZAGY)
Financial summary for Lonza Group AG (LZAGY). Price: 62.11, daily change: $0.00 / 0.00%. Market cap: 44,193,333,248. Performance for all periods at a glance.
Company Details
Employees: 16866
Sector: Health technology
Industry: Biotechnology
Country: Switzerland
Details
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.